Taiwan-listed stock · 6446
PharmaEssentia (6446): insider filings
In the last 12 months, company insiders filed 4 open-market buys and 34 sales.
- Insider buys / sales
- 4 / 3412 months
- Insiders reporting
- 1112 months
- Last close
- NT$1,18512 Oct 2026
- One-year change
- +145.2%
38 disclosed buys and sales on record since 15 October 2025. Directors, managers and holders of more than 10% report each month’s changes by the 15th of the next. Counts are shares bought and sold on the exchange, valued at the month-end close; stock dividends, gifts, inheritance, family transfers and declared plans are left out.
Latest disclosures
| Disclosed | Filed by | Type | Amount | Traded |
|---|---|---|---|---|
| 林俐伶Company insider (Taiwan) | Sale | ≈ $264K | ||
| 張雪玲Company insider (Taiwan) | Sale | ≈ $65.7K | ||
| 張進德Company insider (Taiwan) | Buy | ≈ $32.8K | ||
| 李伸一Company insider (Taiwan) | Sale | ≈ $328K | ||
| 張雪玲Company insider (Taiwan) | Sale | ≈ $1.7M | ||
| 林俐伶Company insider (Taiwan) | Sale | ≈ $304K | ||
| 秦小強Albert QinCompany insider (Taiwan) | Sale | ≈ $1.1M | ||
| 李伸一Company insider (Taiwan) | Sale | ≈ $22.4K |